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ABSTRACT
Human metapneumovirus (hMPV) is a newly identiﬁed paramyxovirus that has been associated with
respiratory tract illness in children aged < 5 years, the elderly, and immunocompromised patients. This
study determined the frequency of respiratory tract infections (RTIs) associated with hMPV in the
Republic of Ireland. Bronchoalveolar lavage (BAL) samples from 168 adult patients and respiratory
specimens from 122 children aged < 5 years were collected between September 2003 and May 2004. The
virus was detected by reverse-transcription (RT)-PCR using hMPV polymerase (L) and matrix
(M)-speciﬁc primers in four (2.4%) of 171 BAL specimens obtained from 168 adults. No other respiratory
virus was detected in these specimens, and no hMPV RNA was detected in respiratory specimens from
children during the same time period. In all four adult cases, two of whom had underlying disease, hMPV
was associated with mild, self-limiting upper RTIs. The most common clinical ﬁndings included fever
(3 ⁄ 4 patients), cough (4 ⁄ 4) and rhinorrhoea (3 ⁄ 4). No patient died as a result of these RTI episodes.
Phylogenetic analysis was performed using the ampliﬁed regions of the M and fusion (F) genes of hMPV.
The Irish isolates belonged to cluster 1B, and did not show a separate Irish sub-lineage.
Keywords hMPV, human metapneumovirus, molecular epidemiology, phylogenetics, respiratory tract infections,
RT-PCR
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INTRODUCTION
Acute respiratory tract infections (RTIs) remain a
leading cause of illness worldwide. They affect
individuals of all ages, and are responsible for a
signiﬁcant loss of productive time, as well as
being important factors in terms of morbidity and
mortality of the elderly population [1]. The
viruses associated most frequently with RTIs
include inﬂuenza virus, parainﬂuenza virus,
human respiratory syncytial virus (hRSV), adeno-
virus, coronavirus and rhinovirus, but the aetio-
logical agents remain unknown in a substantial
proportion of cases.
In 2001, a new paramyxovirus, human meta-
pneumovirus (hMPV), was identiﬁed in The
Netherlands and linked to acute RTI in children
[2]. hMPV has been recognised as the ﬁrst human
pathogen within the genus Metapneumovirus, sub-
family Pneumovirinae (family Paramyxoviridae)
[2]. Phylogenetic analysis has demonstrated the
existence of two genetic subgroups of hMPV,
exempliﬁed by the Canadian strains CAN97-83
(genotype 1) and CAN98-75 (genotype 2) [3]. By
analogy with hRSV, it was assumed that these
distinct genetic lineages would represent different
antigenic subgroups. However, it has been shown
that the two hMPV genetic groups are highly
related antigenically, and that the fusion protein
is a major contributor to this antigenic relatedness
[4]. No zoonotic source for hMPV is known,
despite similarities between hMPV and avian
pneumovirus type C [2,5]. Infection appears to be
seasonal, and resembles that caused by hRSV in
that it occurs primarily, but not exclusively, in the
winter months [2,6,7].
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The relative importance of hMPV in virus RTIs
is still unknown. However, hMPV has been
associated with acute RTIs in neonates and
children [2,7,8], young and elderly adults [9],
and immunocompromised patients [10]. Respir-
atory illness in these patient groups ranges from
upper RTIs to severe bronchiolitis and pneumonia
[11]. hMPV is ubiquitous and circulates world-
wide. The virus has been identiﬁed in Asia
[12,13], Australia [14], North America [15–17]
and Brazil [18]. RTIs associated with hMPV
infection in patients from the Republic of Ireland
have never been investigated. In the present
study, the frequency of hMPV-associated infec-
tion in Irish children and adults during the
2003–2004 inﬂuenza season was determined. The
clinical features of hMPV-positive patients were
reviewed, and phylogenetic analysis based on
matrix (M) and fusion (F) gene sequences was
performed to evaluate their genetic diversity.
MATERIALS AND METHODS
Specimen collection and testing
Retrospective testing for hMPV was performed on 171 bron-
choalveolar lavage (BAL) specimens obtained from 168 adults
with RTIs in different wards at St James’s Hospital, Dublin,
between September 2003 and May 2004. During the same
period, 122 respiratory specimens, comprising 102 nasopha-
ryngeal aspirates (NPAs), 12 BALs and eight sputum samples,
were collected from children aged < 5 years in Republic of
Ireland hospitals. All samples were tested retrospectively for
hMPV RNA by reverse-transcription (RT)-PCR (see below).
Routine testing for other respiratory viruses included inﬂuen-
za A and B viruses, hRSV, adenovirus, and parainﬂuenza virus
types 1–4. Direct immunoﬂuorescence on cells present in BAL
and NPA samples was performed using a commercial
respiratory virus screen kit (Imagen; DakoCytomation, Gal-
way, Ireland) with ﬂuorescently-labelled monoclonal anti-
bodies to hRSV, inﬂuenza A and B viruses, adenovirus and
parainﬂuenza virus types 1–3. Respiratory virus isolation was
performed using the Madin Darby canine kidney, human lung
adenocarcinoma (A549), human embryonic lung ﬁbroblast and
fetal rhesus monkey kidney cell lines. All BAL and NPA
samples were stored at + 4C during processing, and were then
stored at ) 80C.
Isolation of RNA from clinical specimens and RT-PCR
RNA was extracted from 500 lL of BAL or respiratory
specimen using the RNeasy kit (Qiagen, Crawley, UK) accord-
ing to the manufacturer’s instructions. Virus RNA was
ampliﬁed in a one-step RT-PCR (Qiagen, Crawley, UK) that
contained 5 lL of 5· OneStep RT-PCR buffer (Qiagen), 400 lM
each dNTP, 0.6 lM each primer (see below), 1 lL of OneStep
RT-PCR enzyme mix (Qiagen) and 5 lL of RNA extract in a
ﬁnal reaction volume of 25 lL. Screening was performed with
polymerase (L) gene primers L6 (5¢-CATGCCCACTATAA-
AAGGTCAG-3¢) and L7 (5¢-ACCCCAGTCTTTCTTGAAA-3¢),
which amplify a 170-bp fragment from nucleotides 11321–
11490 (based on the prototype hMPV Dutch strain 00-1) [2,19].
Screening of the BAL or respiratory specimen cohort was also
performed with matrix (M) gene primers hMPV-MF1 (5¢-AA-
GTGAATGCATCAGCCCAAG-3¢) and hMPV-MR1 (5¢-CACA-
GACTGTGAGTTTGTCAAA-3¢), which amplify a 120-bp
fragment from nucleotides 2376–2495 from hMPV strain 00-1
[20], to conﬁrm the results of the L-gene RT-PCR. RT-PCR
parameters comprised 50C for 30 min and 95C for 15 min,
followed by 40 cycles of 94C for 1 min, 50C for 1 min and
72C for 1 min, with a ﬁnal extension step at 72C for 10 min.
The RT-PCR products were visualised on a UV transillumina-
tor following agarose gel electrophoresis as described previ-
ously [21]. Where necessary, amplicons were puriﬁed with a
PCR puriﬁcation kit (Qiagen).
DNA sequencing and phylogenetic analysis
A fragment of the hMPV M gene was ampliﬁed with primers
hMPV-MR1 (see above) and hMPV-MF2 (5¢-ATGGAGTCC-
TATCTAGTAGACA-3¢), which amplify a 331-bp fragment
from nucleotides 2165–2495 [20]. To compare with the M-gene
phylogenetic reconstruction, a 450-bp fragment of the hMPV
fusion (F) gene [15] was ampliﬁed with primers MPVF1f (5¢-
CTTTGGACTTAATGACAGATG-3¢) and MPVF1r (5¢-GTCTT-
CCTGTGCTAACTTTG-3¢), corresponding to nucleotides
3704–4153. Automated DNA sequencing was performed on
both strands with an ABI Prism 3730XL DNA Analyser (Perkin
Elmer-Applied Biosystems, Warrington, UK) as described
previously [21]. The nucleotide sequences were aligned with
known sequences from GenBank, and multiple-sequence
alignments were assembled in MacClade 4 [22]. Modeltest
[23] was employed to select the best evolutionary model by
means of hierarchical likelihood ratio tests. In addition, the
Logdet paralinear model was applied to the F-gene data.
Phylogenetic reconstructions and bootstrap analysis (1000
replicates) were carried out in Paup* 4.0 [24] by distance and
maximum-likelihood methods.
RESULTS
Clinical and virological ﬁndings
In total, 122 respiratory specimens obtained from
122 children aged £ 5 years were negative for
hMPV RNA by RT-PCR. Testing for respiratory
viruses by direct immunoﬂuorescence and cell
culture showed that 12 of these specimens were
positive for hRSV, ﬁve for inﬂuenza A virus, three
for parainﬂuenza virus type 3, and one for
parainﬂuenza virus type 1.
Of 171 BAL samples from 168 adult patients
with RTI, four (2.4%) were positive for hMPV
RNA. No other respiratory viruses were detected
by direct immunoﬂuorescence or cell culture in
these four samples. Overall, 91.2% of samples
were negative for all viruses tested. The clinical
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features on admission to St James’s Hospital
Dublin of the four adults in whom hMPV RNA
was detected are summarised in Table 1. The four
patients, aged 48–72 years, were each admitted
with symptoms and signs consistent with com-
munity-acquired RTI. There was no epidemiolog-
ical relationship between these patients, with each
one presenting at least 6 weeks apart. All four had
at least one underlying illness (Table 1). The most
common clinical ﬁndings were fever (3 ⁄ 4), cough
(4 ⁄ 4) and rhinorrhoea (3 ⁄ 4). Two of the four
patients (Table 1; patients 2 and 4) had clinical
presentations consistent with upper RTI, but
without radiological evidence of lower respirat-
ory tract involvement. Patient 4 was lymphocy-
topenic (absolute lymphocyte count < 300 ⁄mm3)
following treatment with alemtuzumab for
refractory chronic lymphocytic leukaemia.
Patients 1 and 3 had radiological evidence sug-
gestive of lower RTI. However, patient 1 had right
lower-lobe radiological changes, associated with
right bronchial squamous cell carcinoma, and a
clinical presentation consistent with an upper RTI
associated with hMPV, with underlying lung
neoplasia. Patient 3 had bilateral pneumonia
and sepsis caused by Streptococcus pneumoniae,
and required antibiotic treatment and mechanical
ventilation in the intensive care unit. No patient
died as a result of these episodes of RTI.
Eleven (BAL) specimens from ﬁve other
patients were positive for other respiratory
viruses following routine respiratory virology
investigations. Two patients with upper RTI
following stem-cell transplantation were positive
on direct immunoﬂuorescence and cell culture for
inﬂuenza A virus. Although these patients
became asymptomatic, they remained positive
by both methods on repeated testing for inﬂuenza
A virus for 5 weeks following a 7-day course of
treatment with oseltamivir, consistent with
asymptomatic shedding of the virus in severely
immunocompromised hosts. One patient with
underlying asthma was positive by direct immu-
noﬂuorescence and cell culture for inﬂuenza B
virus, while two other elderly patients were
positive for parainﬂuenza type 3 virus.
Phylogenetics
In total, 229 hMPV F-gene sequences of the same
fragment length as those produced from the Irish
isolates (450 bp) were downloaded from the
GenBank database. After identical, non-Irish,
sequences were removed, 66 sequences remained
for analysis. Trees reconstructed using maximum-
likelihood or distance methods under the best
model of sequence evolution, chosen by Model-
test (HKY + I + G), did not show cluster II to be
monophyletic. However, the neighbour-joining
tree, drawn using Logdet distances, showed a
highly supported monophyletic grouping for this
cluster (Fig. 1). Cluster I was monophyletic under
all analyses with high bootstrap support, and all
hMPV sequences fell into a single cluster with
Table 1. Clinical features of four adults with human metapneumovirus (hMPV)-associated respiratory tract infection
Lab. no.
(patient
no.)
Age
(years)
Sex Underlying disease
Presenting symptoms
and signs
Radiological
ﬁndings
Histological
ﬁndings
Other laboratory
ﬁndings Diagnosis
ROI82
(1)
72
Male
Squamous cell
carcinoma of lung
Fever, cough, rhinorrhoea,
wheezing, crepitations
Consolidation and
atelectasis of right
lower lobe
Bronchial biopsy
showed evidence of
squamous cell
carcinoma
WBC 8 ⁄mm3
Sputum—no bacterial
growth
Squamous cell carcinoma
with upper respiratory
tract infection caused by
hMPV
ROI135
(2)
48
Female
Asthma Cough, rhinorrhoea,
wheezing
Normal Bronchial washings
showed benign
respiratory tract
elements with scanty
neutrophils
WBC 6 ⁄mm3
Sputum—no bacterial
growth
Exacerbation of asthma
due to hMPV infection
ROI48
(3)
66
Male
Chronic obstructive
airways disease
Fever, cough, rhinorrhoea,
hypotension, tachycardia,
tachypnoea
Right lower lobe
consolidation, left
basal consolidation
Not done WBC 25 ⁄mm3
Streptococcus
pneumoniae in blood
cultures, sputum
Bacterial pneumonia and
hMPV upper respiratory
tract infection
superimposed on chronic
obstructive airways
disease
ROI16
(4)
63
Male
Chronic lymphocytic
leukaemia
Fever, rhinorrhoea, cough Normal Not done WBC—absolute
lymphocyte count
< 300 ⁄mm3
Sputum—no bacterial
growth
hMPV-associated upper
respiratory tract infection
in immunocompromised
patient with
lymphocytopenia
WBC, white blood cell count.
368 Clinical Microbiology and Infection, Volume 11 Number 5, May 2005
 2005 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 11, 366–371
APV-C as outgroup. All Irish isolates were part of
cluster IB under all analyses, but did not form a
separate Irish sub-cluster, although ROI16 was
more closely related to NI143 than either was to
the other Irish isolates. Three of the four Irish
sequences were identical (ROI48, ROI82 and
ROI135).
In total, 25 hMPV M-gene sequences from
GenBank of the same length as the Irish sequences
(287 bp) were included for analysis, including
three outgroup sequences. Identical sequences
were collapsed (except for the seven Irish isolates),
leaving 25 sequences for analysis. The maximum-
likelihood phylogeny is shown in Fig. 1, with
bootstrap values derived from neighbour-joining.
Clusters I and II were clearly separated on this
tree, each with high bootstrap support. Irish
isolate ROI16 was identical to NI143, while iso-
lates ROI48, ROI82 and ROI135 were also identi-
cal. Again, all isolates were within genetic group
1B.
DISCUSSION
The present study is the ﬁrst to document the
occurrence of hMPV in the Republic of Ireland.
The study conﬁrmed that hMPV infection can
occur in adults, including elderly and immuno-
compromised patients. Since 100% seropreva-
lence to hMPV, with stable neutralising titres,
has been reported in young adults and older
individuals [6], the hMPV-associated infections
reported in the present study probably reﬂect re-
infection with the virus. The relatively low detec-
tion rate (2.4%) of hMPV in this study is not
unusual. Thus, three samples from a random
selection of 200 NPAs collected during 2001 in an
Australian study [14], and nine (2.2%) of 408
Fig. 1. Phylogenetic reconstructions of the Irish hMPV F and M genes. The F-gene tree (left) was reconstructed from
Logdet distances using neighbour-joining. The M-gene tree (right) was reconstructed using the maximum-likelihood
method under the TVM + I + G model. The alpha parameter of the gamma distribution and the proportion of invariable
sites were estimated at 1.68 and 0.44, respectively. Bootstrap proportions (1000 replicates) are plotted at the branches of
each phylogram to show support values.
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nasal and throat swabs tested in the UK [25], were
positive by RT-PCR for hMPV RNA.
The clinical features associated with hMPV
infection in adults in this study were not sufﬁ-
ciently distinctive to differentiate hMPV from
other respiratory viruses. The exacerbation of
asthma described here supports the association of
hMPV infection with asthma. While viruses such
as hRSV and rhinoviruses have been suggested as
important triggers of asthma exacerbation in
older children and adults, a possible association
between hMPV infection and asthma has been
indicated [7,13]. The ﬁnding in this study war-
rants further research on this association in Irish
patients.
While no other common respiratory virus was
identiﬁed in the four Irish adults in whom hMPV
RNA was detected by RT-PCR, severe pneumo-
coccal sepsis occurred in one patient with chronic
obstructive airways disease. Whether hMPV
infection predisposed this individual to invasive
S. pneumoniae infection is unknown.
hMPV can cause severe RTI in immunocom-
promised individuals [26], but the present study
found only mild illness in an individual with
underlying squamous cell carcinoma, and also in
a haematology patient with severe lymphocy-
topenia following treatment with alemtuzumab
(Table 1). Both patients presented with upper RTI,
but did not develop pneumonia. In other studies,
hMPV was the sole pathogen detected in three
patients with underlying acute lymphoblastic
leukaemia who presented with RTIs and subse-
quently died [10,11,27]. However, another hMPV-
infected immunocompromised child with acute
lymphoblastic leukaemia recovered without
speciﬁc antiviral treatment [13]. These differences
in clinical presentation may be related to different
biological properties of strains of hMPV. How-
ever, while differences in virulence of hRSV
subgroups A and B have been reported [28], no
data exist to compare the virulence of the two
known genetic lineages of hMPV.
Surprisingly, hMPV was not detected in 122
respiratory specimens obtained from children
aged £ 5 years who were hospitalised with RTIs.
The frequency of hMPV infection in hospitalised
children was reported as 5.5% in one study, with
hMPV-positive children presenting with mild-
to-severe RTIs [13]. Furthermore, other data indi-
cate that hMPV accounts for at least 5–7% of
RTIs in hospitalised children [26]. Specimens,
including BALs, collected in the present study
were obtained in the same period as BALs
from Irish adults with hMPV-associated infec-
tions. Improper storage of the specimens from
children is very unlikely. Retrospective testing for
hRSV by RT-PCR using 66 of the stored speci-
mens proved more sensitive than biological
methods (18.1% vs. 12%; results not shown).
Furthermore, known hMPV-positive NPAs from a
hospital in the UK were used successfully as
positive controls, even though the specimens had
been frozen and thawed on at least two occasions.
An underestimation of the percentage of hMPV-
positive samples was observed when only spec-
imens negative for other respiratory viruses were
tested for hMPV [17]. It is also possible that a new
lineage of hMPV, not ampliﬁed by the primers
used for RT-PCR, could have caused RTIs in
young Irish children. However, phylogenetic
analysis of the hMPV isolates from the four adult
Irish patients showed that the circulating strains
in 2003–2004 belonged to the well-recognised 1B
lineage. It is also possible that the occurrence of
hMPV shows a seasonal variation, perhaps with
sporadic epidemics. Temporal variation in the
pattern of hMPV infection has been demonstrated
in young and elderly adults, with hMPV illness
rates of 1.5% and 7.0% in the winter seasons of
1999–2000 and 2000–2001, respectively [9]. Fur-
thermore, another study [19] showed that the
incidence of hMPV infection in infants varied
substantially from season to season over a 3-year
period, with a positivity rate of 7% in 2001,
compared to 40% in 2000 and 2002.
In conclusion, these results provide further
evidence of the potential importance of hMPV in
RTI in Irish adults of all ages; indeed it may
account for a signiﬁcant proportion of individuals
hospitalised with RTI. Further studies of the
prevalence, risk factors and temporal pattern of
hMPV infection will be needed to determine the
overall clinical signiﬁcance of this virus and its
impact on healthcare services.
NUCLEOTIDE SEQUENCE
ACCESSION NUMBERS
hMPV ROI16 F gene, AY789626; NI143 F gene,
AY789627; ROI48 F gene, AY789628; NI106 F gene,
AY789629; NI107 F gene, AY789630; ROI16 M
gene, AY789631; ROI48 M gene, AY789632; NI106
M gene, AY789633; NI107 M gene, AY789634.
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